(Total Views: 626)
Posted On: 09/02/2020 4:32:32 PM
Post# of 148920
GOOD NEWS RESULTS READY IN OCTOBER
Fast Track approval of leronlimab to treat COVID-19 patients with mild-to-moderate symptoms based upon the trial’s Top-line Report and additional eIND data.
On the suggestion of the MHRA, CytoDyn will submit its current Phase 3 CD12 study for severe-to-critical COVID-19 patients in the UK to the Urgent Public Health (UPH)
https://www.cytodyn.com/newsroom/press-releas...fast-track
GOOD NEWS They Can Submit the PIII Data in October !
xxx.
xx.
x.
Fast Track approval of leronlimab to treat COVID-19 patients with mild-to-moderate symptoms based upon the trial’s Top-line Report and additional eIND data.
On the suggestion of the MHRA, CytoDyn will submit its current Phase 3 CD12 study for severe-to-critical COVID-19 patients in the UK to the Urgent Public Health (UPH)
https://www.cytodyn.com/newsroom/press-releas...fast-track
GOOD NEWS They Can Submit the PIII Data in October !
xxx.
xx.
x.
(2)
(0)Scroll down for more posts ▼
